About Incyte

Incyte is a global biopharmaceutical company based in Wilmington, Delaware, that is focused on finding solutions for serious unmet medical needs through the discovery, development, and commercialization of proprietary therapeutics.

For additional information on Incyte, please visit Incyte.com and follow @Incyte on Twitter. For more information on OPZELURA™ (ruxolitinib) cream 1.5%, visit OpzeluraHCP.com.

Please see below for Important Safety Information, including Boxed Warning for risk of serious infections, mortality, malignancies, major adverse cardiovascular events, and thrombosis.